2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

Mirabilis Medical's Ultrasound Treatment for Uterine Fibroids Approved in Europe

March 23, 2017 -- Mirabilis Medical announced that its system for treating uterine fibroids has received European CE Mark approval. The company also announced receipt of …

Study Evaluates Effect of Surgeon and Hospital Volume on Mortality After EVAR and Open AAA Repair

March 22, 2017 -- Sara L. Zettervall, MD, et al published a study of the effect of surgeon and hospital volume on mortality after open and endovascular aneurysm repair (EVAR) …

Predictive Ability of SVS WIfI Classification System Studied in First-Time Lower Extremity Revascularizations

March 22, 2017 -- Marc L. Schermerhorn, MD, led an investigation of the predictive ability of the Society for Vascular Surgery (SVS) Wound, Ischemia, and foot Infection (…

Intact Vascular's TOBA II Trial Completes Enrollment in Europe and the United States

March 23, 2017 -- Intact Vascular, Inc. announced that the company's Tack Optimized Balloon Angioplasty II (TOBA II) clinical trial has completed enrollment with 210 patie…

Long-Term Outcomes of Gore's Excluder for Infrarenal Aortic Aneurysms Studied in The Netherlands

March 22, 2017 -- A study conducted at two centers in The Netherlands evaluated the long-term outcome of the Excluder abdominal aortic aneurysm (AAA) endoprosthesis (Gore &…

Renal Outcomes Evaluated in Patients Treated With Zenith FEVAR and EVAR Devices

March 21, 2017 -- In European Journal of Vascular and Endovascular Surgery (EJVES), Leonardo Reis de Souza, MD, et al published findings from a study comparing renal outc…

Click here for more News coverage

Current Supplement

Sponsored by GORE & ASSOCIATES

Trust Is Earned

An overview of clinical outcomes and advanced treatment options for endovascular aortic repair.

Current European Supplement

Sponsored by VASCUTEK LTD.

EVARlution

More options and more solutions to treat complex AAA anatomy.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $44.71  -0.04%
AstraZeneca PLC $31.75  1.41%
Avinger $1.62  1.25%
Boston Scientific Corporation $24.69  1.52%
Cardinal Health $81.74  0.63%
Cardiovascular Systems Inc. $28.28  0.64%
CR Bard Inc. $251.00  0.44%
Edwards Lifesciences Corp. $96.00  0.43%
Endologix Inc. $6.87  -0.87%
Vascular Market Price  Change
Johnson and Johnson $125.85  0.29%
Lombard Medical, Inc. $0.66  -1.49%
Medtronic, Inc. $81.10  0.12%
Merit Medical Systems, Inc. $28.90  0.61%
Penumbra, Inc. $81.55  0.55%
Stryker $132.43  -0.06%
Teleflex Inc. $194.49  -0.20%
The Medicines Company $50.45  -0.47%
The Spectranetics Corporation $28.10  0.54%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.